RMD

ResMed Inc
$225.35-$7.59-3.26%Price as of Nov 3, 2026, 9:34 AM ET

Key stats

Market cap
31.7B
Open
—
Day range
—
52-week range
$180.27 – $277.67
Volume
44.4K
Avg volume
1.27M

Earnings

Q1 FY27Beat
Expected$2.70
Actual$2.91
Q4 FY26
Actual$2.64
Q3 FY26
Actual$2.74
Q2 FY26
Actual$2.68

Next earnings call Jan 21, 2027

About

ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia.

Employees
11,370
Headquarters
San Diego, CA